Eggel A, Pennington L, Jardetzky T
Immunol Rev. 2024; 328(1):387-411.
PMID: 39158477
PMC: 11659931.
DOI: 10.1111/imr.13380.
Marra A, Curci P, Franco G, Pittalis G, Tugnoli E, Cavasin D
Cureus. 2024; 16(4):e57917.
PMID: 38601813
PMC: 11004847.
DOI: 10.7759/cureus.57917.
Matsumoto T, Sakurai Y, Tashima N, Matoba T, Kaneko A, Fujiki T
Respirol Case Rep. 2023; 12(1):e01266.
PMID: 38074921
PMC: 10701292.
DOI: 10.1002/rcr2.1266.
Carriera L, Fanto M, Martini A, DAbramo A, Puzio G, Scaramozzino M
J Pers Med. 2023; 13(11).
PMID: 38003909
PMC: 10672189.
DOI: 10.3390/jpm13111594.
Plaza Moral V, Alobid I, Alvarez Rodriguez C, Blanco Aparicio M, Ferreira J, Garcia G
Open Respir Arch. 2023; 5(4):100277.
PMID: 37886027
PMC: 10598226.
DOI: 10.1016/j.opresp.2023.100277.
Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection.
Hamada T, Katsuta T, Aibara K, Nozu S, Nakamura J, Kondo H
Respir Med Case Rep. 2023; 45:101890.
PMID: 37560613
PMC: 10407267.
DOI: 10.1016/j.rmcr.2023.101890.
Specific Therapy for T2 Asthma.
Bagnasco D, Testino E, Nicola S, Melissari L, Russo M, Canevari R
J Pers Med. 2022; 12(4).
PMID: 35455709
PMC: 9031027.
DOI: 10.3390/jpm12040593.
Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.
Eldaabossi S, Awad A, Anshasi N
Respir Med Case Rep. 2021; 34:101520.
PMID: 34692397
PMC: 8512623.
DOI: 10.1016/j.rmcr.2021.101520.
Future Directions for Clinical Respiratory Fungal Research.
Armstrong-James D
Mycopathologia. 2021; 186(5):685-696.
PMID: 34590208
PMC: 8536595.
DOI: 10.1007/s11046-021-00579-5.
Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report.
Nishimura T, Okano T, Naito M, Tsuji C, Iwanaka S, Sakakura Y
World J Clin Cases. 2021; 9(23):6922-6928.
PMID: 34447843
PMC: 8362523.
DOI: 10.12998/wjcc.v9.i23.6922.
Combination Anti-IgE and Anti-IL5 Therapy in a Pediatric Patient With Severe Persistent Asthma.
Fox H, Rotolo S
J Pediatr Pharmacol Ther. 2021; 26(3):306-310.
PMID: 33833634
PMC: 8021240.
DOI: 10.5863/1551-6776-26.3.306.
.
Bauer A, Dickel H, Jakob T, Kleinheinz A, Lippert U, Metz M
Allergo J. 2021; 30(2):40-55.
PMID: 33785991
PMC: 7994058.
DOI: 10.1007/s15007-021-4772-2.
Successful treatment with mepolizumab for allergic bronchopulmonary mycosis complicated with bilateral septic arthritis of the knee joints caused by Methicillin-resistant .
Yanagihara T, Hirota M, Egashira A, Harada Y, Ogo N, Asoh T
Respir Med Case Rep. 2020; 31:101316.
PMID: 33318922
PMC: 7723802.
DOI: 10.1016/j.rmcr.2020.101316.
Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis.
Sunman B, Tural D, Ozsezen B, Emiralioglu N, Yalcin E, Ozcelik U
Front Pediatr. 2020; 8:582964.
PMID: 33194914
PMC: 7606581.
DOI: 10.3389/fped.2020.582964.
Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western Japan.
Matsuura H, Fujiwara K, Omori H, Onishi K, Kuribayashi T, Mitsumune S
Intern Med. 2020; 60(9):1443-1450.
PMID: 33191330
PMC: 8170259.
DOI: 10.2169/internalmedicine.6217-20.
Dual Monoclonal Antibody Therapy for a Severe Asthma Patient.
Domingo C, Pomares X, Moron A, Sogo A
Front Pharmacol. 2020; 11:587621.
PMID: 33101041
PMC: 7556278.
DOI: 10.3389/fphar.2020.587621.
Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review.
Eraso I, Sangiovanni S, Morales E, Fernandez-Trujillo L
Ther Adv Respir Dis. 2020; 14:1753466620961648.
PMID: 33050821
PMC: 7576923.
DOI: 10.1177/1753466620961648.
Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.
Tolebeyan A, Mohammadi O, Vaezi Z, Amini A
Cureus. 2020; 12(8):e9684.
PMID: 32923277
PMC: 7486017.
DOI: 10.7759/cureus.9684.
Allergic bronchopulmonary aspergillosis.
Agarwal R, Sehgal I, Dhooria S, Muthu V, Prasad K, Bal A
Indian J Med Res. 2020; 151(6):529-549.
PMID: 32719226
PMC: 7602921.
DOI: 10.4103/ijmr.IJMR_1187_19.
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.
Davis J, Ferreira D, Paige E, Gedye C, Boyle M
Clin Microbiol Rev. 2020; 33(3).
PMID: 32522746
PMC: 7289788.
DOI: 10.1128/CMR.00035-19.
